[144] New York Times Co. SEC Filing
The New York Times Company filed a Form 144 notifying a proposed sale of 5,000 Class A shares through Fidelity Brokerage, with an aggregate market value of $290,200.50 and an approximate sale date of 08/12/2025 on the NYSE. The 5,000 shares represent roughly 0.0031% of the 162,038,098 shares outstanding, implying an average price of about $58.04 per share.
The filing shows the securities were acquired via restricted stock vesting on 02/21/2025 (687 shares), 02/22/2025 (362), 02/26/2025 (3,560) and 08/10/2025 (391), with the nature of payment listed as compensation. The notice also records a prior sale of 2,500 shares on 05/30/2025 for gross proceeds of $142,065.00. The filer represents no undisclosed material adverse information is known.
La New York Times Company ha depositato un Form 144 notificando la proposta di vendita di 5.000 azioni di Classe A tramite Fidelity Brokerage, con un valore di mercato complessivo di $290,200.50 e una data di vendita approssimativa del 08/12/2025 sul NYSE. Le 5.000 azioni rappresentano circa il 0.0031% delle 162,038,098 azioni in circolazione, implicando un prezzo medio di circa $58.04 per azione.
Il deposito indica che i titoli sono stati acquisiti tramite la maturazione (vesting) di azioni soggette a restrizioni in data 02/21/2025 (687 azioni), 02/22/2025 (362), 02/26/2025 (3,560) e 08/10/2025 (391), con la natura del pagamento indicata come compenso. L'avviso registra inoltre una vendita precedente di 2,500 azioni il 05/30/2025 per proventi lordi di $142,065.00. Il dichiarante afferma di non essere a conoscenza di informazioni materiali avverse non divulgate.
The New York Times Company presentó un Form 144 notificando una propuesta de venta de 5.000 acciones Clase A a través de Fidelity Brokerage, con un valor de mercado agregado de $290,200.50 y una fecha aproximada de venta del 08/12/2025 en la NYSE. Las 5.000 acciones representan aproximadamente el 0.0031% de las 162,038,098 acciones en circulación, lo que implica un precio medio de alrededor de $58.04 por acción.
El documento indica que los valores fueron adquiridos mediante vesting de acciones restringidas el 02/21/2025 (687 acciones), 02/22/2025 (362), 02/26/2025 (3,560) y 08/10/2025 (391), con la naturaleza del pago registrada como compensación. El aviso también registra una venta previa de 2,500 acciones el 05/30/2025 por ingresos brutos de $142,065.00. El declarante manifiesta no tener conocimiento de información adversa material no divulgada.
The New York Times Company는 Form 144를 제출해 Fidelity Brokerage를 통해 Class A 주식 5,000주를 매도할 예정임을 통지했습니다. 총 시가총액은 $290,200.50이며, NYSE 기준 대략적인 매도 예정일은 08/12/2025입니다. 이 5,000주는 발행주식수 162,038,098주의 약 0.0031%에 해당하며, 주당 평균 가격은 약 $58.04로 계산됩니다.
신고서에 따르면 해당 증권은 제한주식(Restricted Stock) 베스팅으로 취득되었으며, 취득일은 02/21/2025(687주), 02/22/2025(362주), 02/26/2025(3,560주) 및 08/10/2025(391주)로 기재되어 있고 지급의 성격은 보수로 표시되어 있습니다. 또한 이 통지에는 05/30/2025에 2,500주를 매도해 총 수익이 $142,065.00였다는 과거 매도 기록이 포함되어 있습니다. 제출자는 공개되지 않은 중대한 불리한 정보가 없음을 표명합니다.
The New York Times Company a déposé un Form 144 notifiant une proposition de vente de 5 000 actions de catégorie A via Fidelity Brokerage, pour une valeur de marché totale de $290,200.50 et une date approximative de vente au 08/12/2025 sur le NYSE. Ces 5 000 actions représentent environ 0,0031% des 162,038,098 actions en circulation, ce qui implique un prix moyen d'environ $58.04 par action.
Le dossier indique que les titres ont été acquis par vesting d'actions restreintes le 02/21/2025 (687 actions), 02/22/2025 (362), 02/26/2025 (3,560) et 08/10/2025 (391), la nature du paiement étant indiquée comme rémunération. L'avis mentionne également une vente antérieure de 2,500 actions le 05/30/2025 pour un produit brut de $142,065.00. Le déclarant déclare ne pas avoir connaissance d'informations défavorables matérielles non divulguées.
The New York Times Company hat ein Form 144 eingereicht und eine geplante Veräußerung von 5.000 Class-A-Aktien über Fidelity Brokerage gemeldet, mit einem gesamten Marktwert von $290,200.50 und einem ungefähren Verkaufsdatum 08/12/2025 an der NYSE. Die 5.000 Aktien entsprechen etwa 0.0031% der 162,038,098 ausstehenden Aktien, was einen durchschnittlichen Preis von rund $58.04 pro Aktie impliziert.
Die Einreichung weist aus, dass die Wertpapiere durch Vesting eingeschränkter Aktien erworben wurden am 02/21/2025 (687), 02/22/2025 (362), 02/26/2025 (3,560) und 08/10/2025 (391), wobei die Zahlungsart als Vergütung angegeben ist. Die Mitteilung verzeichnet außerdem einen vorherigen Verkauf von 2,500 Aktien am 05/30/2025 mit Bruttoerlösen in Höhe von $142,065.00. Der Einreicher erklärt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu kennen.
- Sale size is small relative to the company's outstanding shares (~0.0031%), limiting potential market impact
- Securities were acquired via restricted stock vesting with payment listed as compensation, a routine insider compensation event
- None.
Insights
TL;DR Routine insider filing: small proposed sale tied to recent RSU vesting; immaterial to cap structure.
The Form 144 documents a proposed sale of 5,000 Class A shares with an aggregate value of $290,200.50, representing ~0.0031% of shares outstanding. The shares were obtained through restricted stock vesting and are being routed through a broker on the NYSE. From a market-impact perspective, the size is negligible relative to the company’s outstanding stock, and prior activity includes a 2,500-share sale on 05/30/2025 for $142,065.00. This appears to be a routine disclosure of insider liquidity following compensation-related vesting.
TL;DR Disclosure aligns with Rule 144 requirements; filing confirms shares originated from compensation vesting and includes required seller representations.
The notice identifies the nature of acquisition as restricted stock vesting across multiple dates and specifies compensation as the payment source, which supports compliance with disclosure norms for Rule 144 sales. The filing includes the standard representation that the selling party is not aware of undisclosed material adverse information. Given the small proportion of outstanding shares represented, this filing is procedural rather than governance-critical.
La New York Times Company ha depositato un Form 144 notificando la proposta di vendita di 5.000 azioni di Classe A tramite Fidelity Brokerage, con un valore di mercato complessivo di $290,200.50 e una data di vendita approssimativa del 08/12/2025 sul NYSE. Le 5.000 azioni rappresentano circa il 0.0031% delle 162,038,098 azioni in circolazione, implicando un prezzo medio di circa $58.04 per azione.
Il deposito indica che i titoli sono stati acquisiti tramite la maturazione (vesting) di azioni soggette a restrizioni in data 02/21/2025 (687 azioni), 02/22/2025 (362), 02/26/2025 (3,560) e 08/10/2025 (391), con la natura del pagamento indicata come compenso. L'avviso registra inoltre una vendita precedente di 2,500 azioni il 05/30/2025 per proventi lordi di $142,065.00. Il dichiarante afferma di non essere a conoscenza di informazioni materiali avverse non divulgate.
The New York Times Company presentó un Form 144 notificando una propuesta de venta de 5.000 acciones Clase A a través de Fidelity Brokerage, con un valor de mercado agregado de $290,200.50 y una fecha aproximada de venta del 08/12/2025 en la NYSE. Las 5.000 acciones representan aproximadamente el 0.0031% de las 162,038,098 acciones en circulación, lo que implica un precio medio de alrededor de $58.04 por acción.
El documento indica que los valores fueron adquiridos mediante vesting de acciones restringidas el 02/21/2025 (687 acciones), 02/22/2025 (362), 02/26/2025 (3,560) y 08/10/2025 (391), con la naturaleza del pago registrada como compensación. El aviso también registra una venta previa de 2,500 acciones el 05/30/2025 por ingresos brutos de $142,065.00. El declarante manifiesta no tener conocimiento de información adversa material no divulgada.
The New York Times Company는 Form 144를 제출해 Fidelity Brokerage를 통해 Class A 주식 5,000주를 매도할 예정임을 통지했습니다. 총 시가총액은 $290,200.50이며, NYSE 기준 대략적인 매도 예정일은 08/12/2025입니다. 이 5,000주는 발행주식수 162,038,098주의 약 0.0031%에 해당하며, 주당 평균 가격은 약 $58.04로 계산됩니다.
신고서에 따르면 해당 증권은 제한주식(Restricted Stock) 베스팅으로 취득되었으며, 취득일은 02/21/2025(687주), 02/22/2025(362주), 02/26/2025(3,560주) 및 08/10/2025(391주)로 기재되어 있고 지급의 성격은 보수로 표시되어 있습니다. 또한 이 통지에는 05/30/2025에 2,500주를 매도해 총 수익이 $142,065.00였다는 과거 매도 기록이 포함되어 있습니다. 제출자는 공개되지 않은 중대한 불리한 정보가 없음을 표명합니다.
The New York Times Company a déposé un Form 144 notifiant une proposition de vente de 5 000 actions de catégorie A via Fidelity Brokerage, pour une valeur de marché totale de $290,200.50 et une date approximative de vente au 08/12/2025 sur le NYSE. Ces 5 000 actions représentent environ 0,0031% des 162,038,098 actions en circulation, ce qui implique un prix moyen d'environ $58.04 par action.
Le dossier indique que les titres ont été acquis par vesting d'actions restreintes le 02/21/2025 (687 actions), 02/22/2025 (362), 02/26/2025 (3,560) et 08/10/2025 (391), la nature du paiement étant indiquée comme rémunération. L'avis mentionne également une vente antérieure de 2,500 actions le 05/30/2025 pour un produit brut de $142,065.00. Le déclarant déclare ne pas avoir connaissance d'informations défavorables matérielles non divulguées.
The New York Times Company hat ein Form 144 eingereicht und eine geplante Veräußerung von 5.000 Class-A-Aktien über Fidelity Brokerage gemeldet, mit einem gesamten Marktwert von $290,200.50 und einem ungefähren Verkaufsdatum 08/12/2025 an der NYSE. Die 5.000 Aktien entsprechen etwa 0.0031% der 162,038,098 ausstehenden Aktien, was einen durchschnittlichen Preis von rund $58.04 pro Aktie impliziert.
Die Einreichung weist aus, dass die Wertpapiere durch Vesting eingeschränkter Aktien erworben wurden am 02/21/2025 (687), 02/22/2025 (362), 02/26/2025 (3,560) und 08/10/2025 (391), wobei die Zahlungsart als Vergütung angegeben ist. Die Mitteilung verzeichnet außerdem einen vorherigen Verkauf von 2,500 Aktien am 05/30/2025 mit Bruttoerlösen in Höhe von $142,065.00. Der Einreicher erklärt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu kennen.
FAQ
What does NYT's Form 144 report?
How large is the proposed sale relative to NYT's outstanding shares?
How were the shares acquired that are being sold under the Form 144?
Has the seller recently sold other NYT shares?
On which exchange will the proposed sale occur?
